Serum Ischemia-Modified Albumin Levels in Experimental Model of Acute Pancreatitis

dc.authoridYildirim, Sule/0000-0002-1815-808X
dc.contributor.authorTopaloglu, Naci
dc.contributor.authorKucuk, Adem
dc.contributor.authorTekin, Mustafa
dc.contributor.authorYildinm, Sule
dc.contributor.authorErbas, Mesut
dc.contributor.authorKiraz, Hasan All
dc.contributor.authorCakir, Dilek Ulker
dc.date.accessioned2025-01-27T20:31:33Z
dc.date.available2025-01-27T20:31:33Z
dc.date.issued2015
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractObjective: To establish whether the Ischemia-Modified Albumin (IMA), a new parameter of oxidative stress, has diagnostic role in experimental acute pancreatitis. Study Design: Randomized controlled trial. Place and Duration of Study: Experimental Animal Center, Canakkale Onsekiz Mart University, Canakkale, Turkey, from May to September 2013. Methodology: Sixteen Sprague-Dawley rats were randomly divided into two groups (n=8 each): Sham and AP groups. AP was induced by ligation of pancreatic duct. Serum IMA, amylase, lipase, AST, ALT and CRP were determined. The severity of pancreatitis was scored by a blinded pathologist under microscope. Results: Serum IMA levels in the AP group increased significantly compared with the control group (p < 0.05). There was also a strong positive correlation between amylase and IMA levels. Conclusion: The present study showed in a rodent model that serum IMA might serve as an additional marker to monitor inflammation during pancreatitis.
dc.identifier.endpage398
dc.identifier.issn1022-386X
dc.identifier.issn1681-7168
dc.identifier.issue6
dc.identifier.pmid26100988
dc.identifier.startpage395
dc.identifier.urihttps://hdl.handle.net/20.500.12428/23193
dc.identifier.volume25
dc.identifier.wosWOS:000356648600002
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherColl Physicians & Surgeons Pakistan
dc.relation.ispartofJcpsp-Journal of The College of Physicians and Surgeons Pakistan
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectAmylase
dc.subjectAcute pancreatitis
dc.subjectRodent
dc.subjectIschemia-modified albumin
dc.titleSerum Ischemia-Modified Albumin Levels in Experimental Model of Acute Pancreatitis
dc.typeArticle

Dosyalar